Kathryn Kellohen
@kkellohen
PharmD @UCSFPharmacy | PGY-1 @UICPhPr | EM PGY-2 @StanfordHealth
ID: 1641905570314682370
31-03-2023 20:49:52
8 Tweet
77 Followers
103 Following
Welcoming our incoming PGY-2 EM resident Kathryn Kellohen to 🌲Stanford Health Care🌲, #TwitterRx and #EmergencyMedicine!!!
Daijah Davis Dr. Kathryn Kellohen, PGY2 EM Resident from Stanford Health Care, will be discussing the RAPID trial which studied self-administered 👃 etripamil for AV-nodal dependent SVT 🫀 Kathryn Kellohen #EMRx #TwitteRx thelancet.com/journals/lance…
Congratulations Temi 🇳🇬 for a great presentation! Also congrats Bryan Gendron Natalija Farrell, PharmD, BCPS, DABAT, FAACT #twitterlessjesscorio glad we were able to face time you in for some of the fun! 😏
So proud of Kathryn Kellohen on her excellent presentation on sugammadex for neuromuscular blockade reversal in the ED at #SAEM24. Great job!!!
Amiodarone isn’t the answer just because it’s listed first. Let’s give lidocaine some love!! Our AnnalsofEM commentary lays out the argument for lidocaine in VT/VF arrest. Time to rethink your ACLS autopilot. #TwitteRx #EMRx Free access link: authors.elsevier.com/a/1kyInib7EMAhG